Abstract

This letter to the editor remarks on additional considerations for the management of febrile neutropenia during the COVID-19 pandemic, in response to the letter by Boutayeb et al.

Authors

Coomes EA; Al-Shamsi HO; Meyers BM; Alhazzani W; Alhuraiji A; Chemaly RF; Almuhanna M; Wolff RA; Ibrahim NK; Chua MLK

Journal

The Oncologist, Vol. 25, No. 8, pp. e1252–e1253

Publisher

Oxford University Press (OUP)

Publication Date

August 1, 2020

DOI

10.1634/theoncologist.2020-0329

ISSN

1083-7159

Contact the Experts team